All state Medicaid programs are required to submit an annual report on the operation of their Medicaid Drug Utilization Review (DUR) programs, which contain information on prescribing patterns, cost savings generated from DUR, program operations, and the adoption of innovative practices. While many DUR policies apply to all pharmaceuticals, the majority of states have policies … Continue reading State Medicaid Fee-for-Service and Managed Care Organization Drug Utilization Review Program Policies